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Abstract: Spondias mombin is a widely cultivated edible plant used in 
folkloric medicine for the treatment of severe cough and other respiratory 
disorders. This study evaluated the anti tubercular property of the stem of S. 
mombin against Mycobacterium tuberculosis (H37Rv and EJA-2011) using 
agar proportion assay on Lowenstein-Jensen medium. Four new compounds 
were isolated from the stem of Spondias mombin and they were identified as 
mombinrin (1), mombincone (2), mombinoate (3) and mombinol (4) 
respectively. Compound 1 is a coumarin, 2-4 are flavonoids. At 40 µg/mL 
concentration, the four compounds exhibited significant inhibitions (p < 
0.05) against M. tuberculosis. At a lower dose of 25 µg/mL, compounds 1 and 
3 exhibited significant antimycobacterial inhibitions (96.0 % and 97.6 % 
respectively; p < 0.05) while compounds 2 and 4 showed moderate 
inhibitions (85.0 % and 88.0 % respectively). The findings show that 
Spondias mombin accumulates antimycobacterial compounds that may serve 
as an important potential source for anti-tubercular agents. 
 
Keywords: Spondias mombin, anti-tubercular compounds, 
antimycobacterial flavonoids, coumarin. 
 
1. Introduction 
 
Spondias mombin Linn. is a widely cultivated economic plant that produces edible floral parts. It 
grows very easily from stakes to make live fences and enclosures. In W Nigeria the tree serves as 
shade and the stem is used for making fence. The fruits (Figure 1) are commonly sold in West African 
markets. Ripe fruits are eaten out-of-hand, or stewed with sugar. The small fruits can be eaten or used 
in making juices and ice creams. The aromatic fruit of S. mombin is rich in vitamins B1 and C [5] 
[15]. The young leaves are cooked as greens and the green fruits pickled in vinegar and eaten like 
olives with salt and chilli. A tea of the flowers and leaves is taken to relieve stomachache, biliousness, 
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urethritis, cystitis, eye and throat inflammations. The plant is used in folkloric medicine for the 
treatment of various diseases. A decoction of the bark is taken in cases of severe cough with 
inflammatory symptoms, giving relief through vomiting [5] [22]. The powdered bark is used for 
treating wounds. The gum is employed as an expectorant and anthelmintic [15]. The plant is reported 
to have antibacterial, antifungal, and antiviral effects [8] [19] [20]; it also has sedative, antiepileptic, 
antipsychotic, anti-diarrhoeal, anti-inflammatory, cytotoxicity properties [1] [2] [20]. The leaf of the 
species has been reported to have an α-amylase inhibitory effect [11]. Although some work has been 
done on the pharmacological properties of crude extracts of S. mombin leaf, there are very few reports 
on the activities of the stem. We previously reported preliminary antimycobacterial activity of the 
stem bark [18] [29].  A few studies have been carried out on the phytochemical composition of the 
leaf of S. mombin but there are scanty reports on the constituents of the stem. The phytochemical, 
proximate, minerals and vitamins A and C compositions of Spondias mombin leaves were determined 
by Igwe et al [13]. The plant accumulates phenolic compounds [12] [17]. The isolation of 2-O-
Caffeoyl-(+)-allohydroxycitric acid and chlorogenic acid butyl ester and a series of 6-alkenyl-salicylic 
acids has been reported [9] [10]. Moreover, SB-202742, an anacardic acid derivative possessing beta-
lactamase inhibitory activity, has been isolated from a hexane extract of the leaf of Spondias mombin 
[7]. In an investigation involving antidiabetic activity, 3β-olean-12-en-3-yl (9Z)-hexadec-9-enoate, an 
α-amylase inhibitor, was isolated from S. mombin leaf [11]. 
 
Tuberculosis is a major cause of death worldwide. World Health Organization reported [24] that each 
year there are around nine million new cases of TB, and close to two million deaths. In 2011, there 
were an estimated 8.7 million new cases of TB (13 % co-infected with HIV) and 1.4 million people 
died from TB [26]. All countries are affected by this disease. Geographically, the burden of TB is 
highest in Asia and Africa. India and China together account for almost 40 % of the world’s TB cases.  
The African Region has 24 % of the world’s cases, and the highest rates of cases and deaths per capita 
[26]. The rapid increase in the number of TB cases in the developing countries is alarming [25].  Of 
great concern is the alarming increase in multidrug-resistant tuberculosis (MDRTB), coupled with the 
extensive drug-resistant (XDR) strains of M. tuberculosis. Worldwide, 3.7 % of new cases and 20 % 
of previously treated cases were estimated to have MDRTB [24] [26]. All these challenges have made 
it necessary to identify new antimycobacterial agents with unique structures to combat this global 
health threatening disease. In the present study we report the isolation of antimycobacterial 
constituents from the stem bark of Spondias mombin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Fruits of Spondias mombin (Bode market in Ibadan, SW Nigeria) 
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2. Materials and Methods 
 
2.1 Plant Material  
 
The stem bark of Spondias mombin L was collected at Badeku in Ibadan, Nigeria in February 2010. 
The plant was identified by Dr. O. A. Ugbogu of the Forestry Research Institute of Nigeria (FRIN), 
Ibadan. A voucher specimen (FHI no. 107896) was deposited in the Herbarium of FRIN.  
 
2.2 General Procedure 
 
Vacuum Liquid Chromatography (VLC) was performed on a Si gel (230-400 mesh, Merck; 
Germany). Gravity column chromatography was performed on a silica gel (70-230 mesh, Merck; 
Germany). Prep-TLC was carried out on Si gel 60 F254 plates (20 x 20 cm, 0.5 mm; Merck, Germany). 
Analytical TLC on Si gel 60 F254 plates (10 x 5 cm, 0.25 mm Merck, Germany). IR spectra were 
recorded on a Thermo Nicolet 100 FT-IR spectrometer. APCI mass spectra were obtained using either 
the positive or negative mode. 1H and 13C NMR spectra were run on a Bruker 600 MHz
 
spectrometer, 
and recorded in CDCl3 using TMS as the internal standard. Mycobacterium tuberculosis H37Rv and 
EJA-2011 strains were provided by the Department of Microbiology, Sacred Heart Hospital, Lantoro 
Oniko, Abeokuta, Nigeria. 
 
2.3 Extraction and Isolation 
 
The extract was prepared from the dried, pulverized stem bark of S. mombin (3.230 kg) by maceration 
with MeOH.  The crude extract was fractionated by VLC on Si gel 230-400 mesh (Merck) with 
gradient elution using hexane, EtOAc, MeOH and water in the order of increasing polarity to afford 
eleven fractions. The anti-Mtb active portion was subjected to gravity column chromatography over a 
silica gel (70-230 mesh) column (110.0 x 3.0 cm) and successively eluted with solvents of increasing 
polarity starting from n-hexane to 100 % MeOH. Twenty-eight fractions (E1-E28) were collected 
from the column. The anti-Mtb active fractions E8
 
and E9 were pooled,
 
based on TLC profiles, and 
then subjected to repeated column chromatography over silica gel to afford compound 1 (11.0 mg).  
Eluates  E16, E17 and E21 from 100 % CHCl3, 100 % CHCl3 and 100 % EtOAc respectively were 
further purified by a PrepTLC glass plate (Silica gel 60 F254, 20 x 20 cm; 0.5 mm; Merck) and 
developed in Pet. Ether/EtOAc/MeOH (7:3:0.5), Hexane/EtOAc 7:3 and Pet. Ether/EtOAc (5:5) 
respectively. Compounds 2, 3 and 4 were respectively isolated from E16, E17 and E21 fractions.  
 
2.4 Antimycobacterial Activity Test 
 
The antimicrobial susceptibility of Mycobacterium tuberculosis was performed by the proportion 
method on an L-J medium. Inoculums for the proportion method were prepared according to standard 
procedures [12] [16]. Rifampicin (RIF) was used as the reference drug at a concentration of 40 µg/ml 
against M. tuberculosis H37Rv standard strain. The column fractions and the pure compounds were 
tested in vitro against the clinical isolate (EJA-2011) at concentrations of 40 µg/ml and 25 µg/ml. The 
prepared bacterial inoculum (0.1 ml) was inoculated on the L-J medium containing the test drug or 
reference drug or drug-free control and then incubated at 37°C for 28 days. Readings were taken on 
the 28th and 42nd days of incubation. Each test was done in quadruplicate.  Activity in the L-J medium 
was evaluated by percentage inhibition and calculated by mean reduction in number of colonies on 
test sample-containing as compared to drug-free controls. 
 
Statistical Analysis 
 
Data was analysed using Student’s t-test and analysis of variance (Anova). The significant differences 
between means were determined at p < 0.05.  
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3. Results  
 
The methanol extract of the stem bark of S. mombin yielded 161.5 g (5.0 %). Repeated column 
chromatography of the anti-Mtb VLC fraction (3.829 g) afforded four molecules (1-4). Compound 1 
was isolated as a greenish solid (11.0 mg) and showed characteristic values of Rf 0.89. IR (KBr) υmax 
2923 (CH3), 2852 (CH2), 1719 (C=O), 1275 (C-O-C) cm-1.  1H and 13C NMR (Table 1). APCI-MS: 
m/z (rel.int.): 352 [M]+ (37), 338 [M+H-CH3]+ (92), 237 [M+H-C5H8O3]+ (26), 222 [M-C5H8O3-CH3]+ 
(100), 151 [M- C5H8O3-CH3-C3H4O2]+ (34); (calcd for C17H20O8). Compound 1 was identified as 8-
methoxy coumaric acetic acid ester and named mombinrin. 
 
Compound 2 was obtained as a light yellow amorphous solid (4.0 mg) and characterized with Rf 0.75, 
IR (KBr) υmax 3434 (O-H), 1710 (C=O) cm-1.  1H and 13C NMR (Table 2).  APCI-MS: m/z (rel.int.): 
578 [M]- (19), 562  [M+H-OH]- (28), 543 [M-Cl]- (34), 527 [M+H-2OH -H2O]- (47), 479 [M+H-2OH-
H2O-CH2Cl]- (28), 473 [M+2H-OH-COOCH3-OCH3]- (56), 451 (44), 369 [M+2H-OH-COOCH3-
OCH3-C8H8]- (100), 295  (63), 279 (28), 255 (34), 239 (44), 233 (84), 220 (34), 177 (14). ( calcd for 
C31H27O9Cl). Compound 2 was elucidated as 3'-Acetyl-5'-chloromethyl-2'-(3’’, 4’’-dihydroxy-phenyl 
butanoid)-3-hydroxy-4-methoxy-4'- methyl ester chalcone. It was named mombincone. 
 
Compound 3 was isolated as greenish amorphous solid (2.0 mg) and characterized with Rf 0.72; IR 
(KBr) υmax 3447 (O-H), 3019 (aromatic), 1690 (C=O), 1216 (C-O-C) cm-1.  1H and 13C-NMR (Table 
3). APCI-MS: m/z (rel.int.): 352 [M]+ (41), 338 [M+H-CH3]+ (21), 311 [M+H-CH3 -HCO]+ (25), 293 
[M+H-CH3 -HCO -H2O]+  (43), 279 (21), 277 [M+H-CH3 -HCO -2OH]+ (38),  193  [M+H- C9H4O3]+ 
(100), 163 [M+H- C11H10O3]+ (9); ( calcd for C20H16O6). Compound 3 was identified as 7-(3-oxo 
propionaldehyde)-flavan-3-methyl ester and named mombinoate. 
 
Compound 4 was isolated yellow amorphous solid (7.0 mg) and characterized as follows: Rf 0.91; IR 
(KBr) υmax 3447 (O-H), 3018 (aromatic), 1714 (C=O), 1616, 1463 (phenyl) 1216   (C-O-C) cm-1. 1H 
and 13C-NMR (Table 4). APCI-MS: m/z (rel.int.): 562 [M+H]+ (21), 531 [M-OCH3]+ 517 [M-COOH]+ 
(15),  475 (41), 391 (100), 338 (44),  282 (45), 205 (32), 166 (25), 162(16), 149 (69), 116 (21),  113 
(48), 107 (34); (calcd for C30H26O11). Compound 4 was identified as 3’, 4’- dimethoxy-5-(3’’, 4’’-
dihydroxy-phenylbutanoid)-3-hydroxy-6-methoxy-7-methyl flavonoate and named mombinol. 
 
 
 
 
           
 
   1        2 
  
O O
OMe
O
O
OMe
CH2OH
1
35
7 9
1'
3'
MeO
5'
6'
OO
OH
HO
OH
OMe
CH2Cl
MeOOC
MeOC
1 3
5
1'3'
5'
1''
3''
5''
7''
9''
Int. J. Pure Appl. Sci. Technol., 19(2) (2013), 76-87 
 
 
80
 
 
 
     
    3 
 
           4 
Figure 2: Structures of compounds (1-4) from Spondias mombin 
 
4. Discussion 
 
The methanol extract of the stem bark of S. mombin exhibited a positive response when tested against 
Mycobacterium tuberculosis. Significant antimycobacterial inhibitions (p < 0.05) were observed in the 
activities (Table 5) of the VLC and open column fractions. Fractionation and purification by repeated 
silica gel column chromatography afforded four compounds (1-4) as pure constituents from the stem-
bark of S. mombin. The IR absorption bands of the compounds (υmax 1719-1690 cm-1) and the ketonic 
carbon signals observed in their 13C NMR spectra suggested the molecules to be carbonyl containing 
groups  — a coumarin (1), a chalcone (2) and two flavonoids (3 and 4).  The elucidation of  the four 
new compounds (Figure 1) were supported by analyses of their MS, 1H and 13C –NMR, HMBC, APT, 
1H-1H COSY, and HSQC data in comparison with the literature data [3] [21] [27].   
 
The HMBC spectrum of compound 1 showed long range correlation signals between C-8 (δC 157.6) 
and OCH3 (δH 3.89), C-21 (δC 171.2) and the germinal protons (δH 2.05, 2.02) of the side chain 
indicating a –CO- CH2- chain. Homonuclear COSY and 2J-coupling constants revealed the 
connectivity of the aromatic protons at δH 6.86ppm (H-3) to δH 7.97 ppm (H-4) and at δH 7.95 ppm 
(H-6) to δH 6.86 ppm (H-7). Fragmentation of the compound 1 with coumarin nucleus produced the 
base peak m/z 222 calculated for C11 H10 O5; peak m/z 338 calculated for C16 H18 O8 and some major 
peaks. The 1H- NMR spectrum of 2 exhibited a one-proton meta-coupled doublet at δ 7.06 ppm (J = 
2.4 Hz) and a one-proton ortho-, meta-coupled doublet doublet at δ 7.08 ppm (J = 8.4, 2.4 Hz) and a  
one-proton ortho-coupled doublet at δ 6.90 ppm (J= 8.4 Hz) ascribed to aromatic protons H-21, H-61 
and H-51 respectively, supporting ABX-type coupling system of ring B.  Mass spectral analysis of 
compound 2 produced peak m/z 562 (M+2,  m/z 564) at the loss of one hydroxyl group and further 
loss of two molecules of water that led to the formation of a peak at m/z 527 (C31H24ClO6) with the 
attendant M+2 peak (m/z 529). This showed the presence of an halogen which was confirmed by the 
existence of a daughter peak at m/z 543 (34%) with the M+1 peak at m/z 544 due to the cleavage of 
chlorine atom from the molecular ion. Furthermore, a loss of CH2Cl from m/z 527 i.e. M+ H-49 
(CH2Cl) gave rise to m/z 479 peak. The base peak m/z 369, calculated for C20 H14 ClO5+, was a 
fragment of the molecular ion m/z 578 at α-cleavage after the loss of OH, COOCH3 and OCH3. The 
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results of the molecular formula analysis showed that the chalcone nucleus contained chlorine 
element. Fragmentation of compound 3 at α-cleavage produced the base peak m/z 193 calculated for 
C11H13 O3 and peak m/z 163 calculated for C9H7O3 (Figure 3). Also, at α- cleavage and σ-bond 
ruptures compound 4 showed some major peaks (base peak m/z 391, calculated for C20H23O8 and peak 
m/z 180 calculated for C10H12O3) that confirmed the structural formula.  
 
Agar proportion assay of the anti-tubercular activity of S. mombin fractions and pure compounds was 
conducted at concentrations of 40 µg/mL and 25 µg/mL.  At a concentration of 40 µg/mL the four 
compounds (1-4) exhibited significant inhibitions (p < 0.05) against M. tuberculosis. These inhibitions 
are comparable to the 99.8 % inhibition exhibited by the reference drug (rifampicin). At a lower 
concentration (25 µg/mL), compounds 1 (mombinrin) and 3 (mombinoate) still demonstrated 
significant antimycobacterial activities (96.0 % and 97.6 % inhibition respectively) at 95 % 
confidence level however, compounds 2 (mombincone) and 4 (mombinol) were less active, with 
percentage inhibitions of 85.0 % and 88.0 % respectively. 
 
A series of flavonoids, chalcones and chalcone-like compounds have been evaluated [14] for 
inhibitory activity against Mycobacterium tuberculosis H37Rv.  Eight compounds from the series 
exhibited > 90 % inhibition on the growth of the bacteria at a concentration of 12.5 mg/mL. Likewise, 
there was a report [4] on flavonoid inhibitors acting as novel antimycobacterial agents targeting 
Rv0636. It was found that butein, isoliquirtigenin, 2, 29, 49-trihydroxychalcone and fisetin inhibit the 
growth of Mycobacterium bovis BCG.  Askun et al. [28] also investigated the in vitro activity of 
methanol extracts of plants used as spices against Mycobacterium tuberculosis and other bacteria. The 
study determined the phenolic composition of two thyme species (Lamiaceae), Origanum 
minutiflorum and Thymbra spicata and assessed their antimycobacterial activity as well as 
antibacterial property. The methanol extracts exhibited high level of activity against Mtb (minimum 
inhibitory concentration MIC 196 µg/ml). In this study, in vitro antimycobacterial assay using agar 
proportion method on L-J medium proved  two molecules  (1 and 3) from Spondias mombin stem bark 
significantly active (p < 0.05) against M. tuberculosis at a given concentration of 25 µg/mL.   
 
Conclusion  
  
The present study isolates four new molecules, mombinrin (1), mombincone (2), mombinoate (3) and 
mombinol (4), from the stem bark of Spondias mombin. The four molecules (1-4) are reported from a 
natural source for the first time. The compounds exhibited significant antimycobacterial property that 
suggests S. mombin, a plant that accumulates juicy-fruits, as a potential source for anti-tubercular 
agents. The folkloric uses of Spondias mombin for cough in the West African sub-region are justified 
by the findings.  
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Table 1. 1H -and 13C –NMR Spectral Data of 1 (CDCl3, 600 MHz) 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
C/H No. 13C PROTON COSY HMBC 
1 O …….     
2 159.7  ……     
3 115.2  6.86 (1H, d, J = 9.0) 4   
4 131.9 7.97 (1H, d, J = 9.0) 3   
5 128.2 ……     
6 129.9  7.95 (1H, d, J = 9.0) 7   
7 114.4  6.86 (1H, d, J = 9.0) 6   
8 157.6  …….     
9 135.4 ………     
10 122.8  ……..     
1' 37.1  2.05, 2.02 (2H, dd, J =17Hz)   C-2' 
2' 171.2 ………     
3' O      
4' 100.1  4.17 (1H, d)      
5' 89.2 4.16 (1H, d)     
6' 60.4   4.04 (2H)    
8-OCH3 59.4 3.89 (3H, s)   C-8  
4'-OCH3 51.9 3.67 (3H, s)     
5'-OCH3 59.3 3.63(3H, s)     
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Table 2. 1H -and 13C –NMR Spectral Data of 2 (CDCl3, 600 MHz) 
 
 
C/H 
No. 
13C PROTON  COSY HMBC C/H 
No. 
13C PROTON  COSY HMBC 
 
 
 
    
 
   
CO  171.2  …..    1''  131.7  …………    
α  123.5  7.54 (1H,d,           
J = 8.4 Hz)  
  β–C 2''  126.5  7.30 (1H,d,           
J = 2.4 Hz)  
  
β  141.1  7.55 (1H,d,           
J = 8.4 Hz)  
  3''  139.3  ……..    
1  129.9  …..    4''  138.4  ……….    
2  116.5  7.06 (1H,d,           
J =2.4 Hz)  
  5''  123.9  7.13 (1H, dd,       
J = 6.0 Hz)  
  
3  147.1  ……   6''  124.1  7.14 (1H, d,         
J = 6.0 , 2.4 Hz)  
  
4  147.7  …….    7''  130.9  6.61 (1H, d,         
J = 7.8 Hz )  
8''  
5  115.9  6.90 (1H,d,           
J =8.4 Hz)  
6 C-4 8''  124.8  7.08 (1H, m)  7'' , 9''  
6  119.1 7.08 (1H,dd,         
J =8.4, 2.4 Hz)  
5 C-2 9''  124.5  5.83 (1H, m )  8''  
1'  114.1  ……   10''  142.9  6.51 (1H, d,         
J = 7.8 Hz)  
 C-2' 
2'  165.8  …….   4-
OCH3  
65.1   4.12 (3H, s)     
3'  128.1  …….   4’a-
OCH3  
64.7  4.10 (3H, s)    
3’a-
CO 
173.8 …….   3-OH  5.01 (1H, s)   
4'  135.8  ……..    3’’-
OH  
 4.98 (1H, s)    
4’a-
CO 
173.4 ……..   4''-OH   4.97 (1H, s)    
5'  129.1  …….    3’b-
CH3  
22.7  2.60 (3H, s )   C-3'  
6'  130.2  7.35 (1H, s)    5'-
CH2Cl  
44.5  4.92 (3H, s )    
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Table 3. 1H -and 13C –NMR Spectral Data of 3 (CDCl3, 600 MHz) 
C/H No. 13C  PROTON  COSY  HMBC  
2  87.5  6.28 (1H,d, J = 10.2 Hz)       C-9 
3  65.2  3.91 (1H, d, )       C-3a 
4  182.5  …        
5  125.3  7.61 (IH, d, J = 8.4 Hz)        
6  113.4  7.54 (1H, d, J =8.4 Hz)      
7  143.7  …        
8  103.2  7.36 (1H, s, t)       C-9 
9  158.6  …        
10  107.4  …        
1'  142.6  …        
2'  128.0  7.13 (IH, dd, J = 8.4, 2.4 Hz)  3'     
3'  129.7  7.08 (1H, dd, J = 8.4, 2.4 Hz)  2'     
4'  129.0  6.92 (1H, dd, J = 8.4)        
5'  129.9  7.07 (IH, dd, J = 8.4, 2.4 Hz)   6'      
6'  128.2  7.12 (1H, dd, J =8.4, 2.4 Hz)    5'    
1''  192.9  …        
2''  55.9  3.93, 3.92 (2H, d)   3’’  C-3''  
3''  203.8  9.77 (1H, t)    2''    
3a  171.2     
3a-OCH3  56.4  3.95 (3H, S)      
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Table 4. 1H -and 13C –NMR Spectral Data of 4 (CDCl3, 600 MHz) 
C/H 
No.  
13C  PROTON  COSY HMBC  C/H No.  13C  PROTON  COSY HMBC  
1  O  …..      6'' 124.1  7.07 (1H, dd,          
J = 6.0, J = 2.4 Hz) 
   
2  135.9  ….      7'' 130.9  6.90 (1H, dd,          
J =  6.0 Hz) 
8''   
3  128.8  ……      8'' 124.8  7.08 (1H, dd;         
J =  6.0, J = 2.4 Hz) 
7'', 9''   
4  173.4  ….      9'' 124.5  5.85 (1H, m) 8''   
5  151.8  ….      10'' 139.3  6.51 (1H, d, J = 18)  C-5 
6  143.1  ….      6-OCH3 68.2   2.87 (3H, s)     
7  135.2  …..   7b-OCH3  60.4  4.06 (3H, s)  C-7a 
7a  167.8  ….      3-OH  5.08 (1H, s)  C-2  
8  123.5  6.99 (1H, s)   C-9  3'-OMe  64.7  3.78 (3H, s)    
9  152.1  ….      4'-OMe  63.1  3.80 (3H, s)    
10  114.1  ….      3''-OH   7.36 (1H, s)    
1'  130.9  ….      4''-OH   7.35 (1H, s)    
2'  116.1  7.54 (1H, d,      
J = 2.4 Hz)  
 C-3'        
3'  147.6  ….            
4'  147.1  ….           
5'  115.9  6.60 (1H, d,      
J = 8.4 Hz)  
6'    
 
   
 
6'  119.1  7.53 (1H, d,      
J =  8.4, 2.4 Hz)  
5'         
1''  131.2  ….           
2''  126.5  7.30 (1H, d,     
J= 2.4 Hz)  
        
 
3''  142.9  ….           
4''  138.5  ….           
5''  123.9  7.13 (1H, d,      
J = 6.0 Hz)  
  C-6''      
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Table 5.  In vitro antimycobacterial activity of Spondias mombin extracts using agar Proportion 
method (Lowenstein Jesen [L-J] medium)  
RIF- Rifampicin  
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